Springhill Fund Asset Management (HK) Co Ltd

CIK 1911270 · View on SEC EDGAR ↗

Portfolio value
$20.9M
#8,899 of 9,443 by 13F value · top 94.2%
Positions
19
As of
March 31, 2025 Data as of Q1 2025

Portfolio value QoQ: -66.1% 13F does not disclose cash

Top 10 holdings weight
82.88%
Top 25 holdings weight
100.00%
Positions above 1%
18
Effective number of positions
10.9

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q1 2025: 32.66% Est. buys $13,461,133 · sells $57,165,711

New positions
13
Increased
2
Decreased
4
Closed
11
On this page

Performance vs S&P 500

Tracked Q4 2024–Q1 2025
-6.2%
S&P 500 total return (same window)
-6.5%
Excess return
+0.3%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

Healthcare
98.8%
Other/Unmapped
1.2%

Full portfolio 19 positions

Type Streak 8Q trend
VRNA Verona Pharma plc - American Depositary Shares $4,031,552 19.32% 63,499 $-2,258,839 Down ×1
SMMT Summit Therapeutics Inc. - Common Stock $2,397,882 11.49% 124,307 Up ×1
JANX Janux Therapeutics, Inc. - Common Stock $2,119,500 10.16% 78,500 $534,716 Up ×1
REGN Regeneron Pharmaceuticals, Inc. - Common Stock $1,648,998 7.90% 2,600 Up ×1
NBIX Neurocrine Biosciences, Inc. - Common Stock $1,505,487 7.21% 13,612 Up ×1
INSM Insmed Incorporated - Common Stock $1,464,158 7.02% 19,192 $-3,334,122 Down ×1
SLNO Soleno Therapeutics, Inc. - Common Stock $1,418,854 6.80% 19,858 $1,338,259 Up ×1
JAZZ Jazz Pharmaceuticals plc - Ordinary Shares $1,223,250 5.86% 9,853 Up ×1
AKRO Akero Therapeutics, Inc. - Common Stock $806,564 3.87% 19,925 $-3,399,820 Down ×1
ARGX argenx SE - American Depositary Shares $678,277 3.25% 1,146 Up ×1
LLY Eli Lilly and Company Common Stock $673,943 3.23% 816 Up ×1
PTGX Protagonist Therapeutics, Inc. - Common Stock $621,861 2.98% 12,859 Up ×1
TGTX TG Therapeutics, Inc. - Common Stock $532,305 2.55% 13,500 Up ×1
TARS Tarsus Pharmaceuticals, Inc. - Common Stock $363,494 1.74% 7,076 Up ×1
ASND Ascendis Pharma A/S - American Depositary Shares $338,684 1.62% 2,173 Up ×1
RYTM Rhythm Pharmaceuticals, Inc. - Common Stock $332,493 1.59% 6,277 Up ×1
BNTX BioNTech SE - American Depositary Shares $273,180 1.31% 3,000 Up ×1
SWTX $260,235 1.25% 5,897 Up ×1
COGT Cogent Biosciences, Inc. - Common Stock $176,651 0.85% 29,491 $-4,102,070 Down ×1

Biggest new bets

New positions opened this quarter, largest first.

Security Value Shares % of portfolio
SMMT $2,397,882 124,307 11.49%
REGN $1,648,998 2,600 7.90%
NBIX $1,505,487 13,612 7.21%
JAZZ $1,223,250 9,853 5.86%
ARGX $678,277 1,146 3.25%
LLY $673,943 816 3.23%
PTGX $621,861 12,859 2.98%
TGTX $532,305 13,500 2.55%
TARS $363,494 7,076 1.74%
ASND $338,684 2,173 1.62%
RYTM $332,493 6,277 1.59%
BNTX $273,180 3,000 1.31%
SWTX $260,235 5,897 1.25%

Top movers (QoQ)

Security Action Shares Δ Value Δ
INSM Trimmed -50K -$3.3M
VRNA Trimmed -72K -$2.3M
JANX Bought more +49K +$535K

3 positions hidden (data completeness check)

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarter Shares before Value before Price since exit
LEGN March 31, 2025 190,800 $6,208,632 -35.8%
CYTK March 31, 2025 130,735 $6,149,774 92.8%
AZN March 31, 2025 76,500 $5,012,280 125.2%
VERA March 31, 2025 109,400 $4,626,526 31.8%
MRUS March 31, 2025 83,800 $3,523,790 No longer tracked
CGEM March 31, 2025 276,400 $3,366,552 187.5%
DYN March 31, 2025 131,200 $3,091,072 152.3%
NRIX March 31, 2025 160,500 $3,023,820 127.9%
DRUG March 31, 2025 60,648 $2,184,541 117.4%
BCYC March 31, 2025 116,400 $1,629,600 -48.6%
ABVX March 31, 2025 207,600 $1,519,632 1811.2%